ebomi
Colour theme
Sign in
Insider · CIK 0001580575

Baker Bros. Advisors (Gp) LLC

CIK 0001580575 Name as filed on the most recent filing

Filed as Baker Bros. Advisors (Gp) LLC (205)

2,200 transaction lines · from 205 filings · filed 2013-08-02 to 2026-07-16 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

0 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2026-07-14 S, Open-market sale Celcuity Inc.CELC 2 lines 317,750,000, disposed Open Form 4 filing 0001193125-26-306299
2026-05-22 S, Open-market sale BeOne Medicines Ltd.ONC 4 lines 261,981, disposed Open Form 4 filing 0001193125-26-242066
2025-12-18 P, Open-market purchase Kodiak Sciences Inc.KOD 2 lines 60,000,008, acquired Open Form 4 filing 0001193125-25-326820
2025-12-11 P, Open-market purchase Kymera Therapeutics, Inc.KYMR 2 lines 172,499,918, acquired Open Form 4 filing 0001193125-25-315999
2025-11-20 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 4 lines 261,846, acquired Open Form 4 filing 0001193125-25-293698
2025-11-12 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 4 lines 781,638, acquired Open Form 4 filing 0001193125-25-278038
2025-11-11 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 4 lines 348,193, acquired Open Form 4 filing 0001193125-25-278038
2025-11-10 P, Open-market purchase Entrada Therapeutics, Inc.TRDA 4 lines 222,756, acquired Open Form 4 filing 0001193125-25-278038
2025-10-01 S, Open-market sale Kala BIO, Inc.KALA 2 lines 710,729, disposed Open Form 4 filing 0001193125-25-228536
2025-09-30 S, Open-market sale Kala BIO, Inc.KALA 2 lines 345,993, disposed Open Form 4 filing 0001193125-25-228536
2025-09-08 P, Open-market purchase Celcuity Inc.CELC 4 lines 9,571,319, acquired Open Form 4 filing 0000950170-25-113977
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 5,215,601, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 3,611,889, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 3,672,178, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 1,981,694, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 1,718,969, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 1,553,954, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 1,086,447, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 977,059, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 730,717, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 480,552, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 434,280, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 332,719, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 338,113, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 182,610, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 158,311, acquired Open Form 4 filing 0000950170-25-110502
2025-08-20 P, Open-market purchase Madrigal Pharmaceuticals, Inc.MDGL 143,153, acquired Open Form 4 filing 0000950170-25-110502

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
S, Open-market sale
Open-market sale
P, Open-market purchase
Open-market purchase

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

No transaction line is stored for this entity, so there is nothing to break down by code. The catalog holds its filings; what it does not hold is a single reportable line from them, which is a fact about the parse and about these filings, not about the entity.

How to cite this page

ebomi catalog. Baker Bros. Advisors (GP) LLC, insider transactions. Retrieved 2026-08-24 from https://ebomi.com/insider/0001580575

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.